Company Filing History:
Years Active: 2016-2017
Title: Ngarita Kingi: Innovator in Antiviral Compounds
Introduction
Ngarita Kingi is a prominent inventor based in Alvsjo, Sweden. She has made significant contributions to the field of antiviral research, particularly focusing on compounds that target influenza viruses. With a total of 2 patents, her work is paving the way for new therapeutic options in the fight against viral infections.
Latest Patents
Ngarita's latest patents include innovative compounds and methods that demonstrate antiviral activity. One notable patent describes thiol derivatives of a general formula that exhibit effectiveness against the influenza virus. Specifically, the compound (4-(2-chloro-4-nitrophenyl)piperazin-1-yl)(4-(2-fluoro-6-methoxyphenyl)-1-methyl-1H-1,2,3-triazol-5-yl)methanone is highlighted for its potential benefits. Additionally, she has developed methanethione compounds that serve as antiviral agents, particularly for treating influenza, along with methods for preparing these compounds.
Career Highlights
Ngarita Kingi is currently associated with Vironova Influenza AB, where she continues her research and development efforts. Her work is characterized by a commitment to advancing antiviral therapies and improving public health outcomes.
Collaborations
Throughout her career, Ngarita has collaborated with notable colleagues, including Mohammed Homman and Jan Bergman. These partnerships have enhanced her research capabilities and contributed to the success of her projects.
Conclusion
Ngarita Kingi is a dedicated inventor whose work in antiviral compounds is making a significant impact in the medical field. Her innovative approaches and collaborations are essential in the ongoing battle against influenza and other viral infections.